AIMC Topic: Drug Development

Clear Filters Showing 211 to 220 of 318 articles

Artificial Intelligence for Clinical Trial Design.

Trends in pharmacological sciences
Clinical trials consume the latter half of the 10 to 15 year, 1.5-2.0 billion USD, development cycle for bringing a single new drug to market. Hence, a failed trial sinks not only the investment into the trial itself but also the preclinical developm...

The Missing Pieces of Artificial Intelligence in Medicine.

Trends in pharmacological sciences
Stakeholders across the entire healthcare chain are looking to incorporate artificial intelligence (AI) into their decision-making process. From early-stage drug discovery to clinical decision support systems, we have seen examples of how AI can impr...

Trader as a new optimization algorithm predicts drug-target interactions efficiently.

Scientific reports
Several machine learning approaches have been proposed for predicting new benefits of the existing drugs. Although these methods have introduced new usage(s) of some medications, efficient methods can lead to more accurate predictions. To this end, w...

A Study on the Application and Use of Artificial Intelligence to Support Drug Development.

Clinical therapeutics
PURPOSE: The Tufts Center for the Study of Drug Development (CSDD) and the Drug Information Association (DIA) in collaboration with 8 pharmaceutical and biotechnology companies conducted a study examining the adoption and effect of artificial intelli...

Exploiting machine learning for end-to-end drug discovery and development.

Nature materials
A variety of machine learning methods such as naive Bayesian, support vector machines and more recently deep neural networks are demonstrating their utility for drug discovery and development. These leverage the generally bigger datasets created from...

Predicting drug-target interactions using Lasso with random forest based on evolutionary information and chemical structure.

Genomics
The identification of drug-target interactions has great significance for pharmaceutical scientific research. Since traditional experimental methods identifying drug-target interactions is costly and time-consuming, the use of machine learning method...

Learning for Personalized Medicine: A Comprehensive Review From a Deep Learning Perspective.

IEEE reviews in biomedical engineering
With the recent advancements in analyzing high-volume, complex, and unstructured data, modern learning methods are playing an increasingly critical role in the field of personalized medicine. Personalized medicine (i.e., providing tailored medical tr...